Suchergebnisse - "Shiu, Kai-Keen"

PubPharm (5)

1

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859) : a multicentre, randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Rha, S. | Oh, D. | Yañez, P. | +121

2

Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer

enthalten in: Cancer science | 2023

von Yoshino, T. | Andre, T. | Kim, T. | +17

3

Trifluridine/Tipiracil in Metastatic Colorectal Cancer : A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors

enthalten in: Clinical colorectal cancer | 2021

von Stavraka, C. | Pouptsis, A. | Synowiec, A. | +19

4

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

enthalten in: The New England journal of medicine | 2020

von André, T. | Shiu, K. | Kim, T. | +119

CommentIn: N Engl J Med. 2020 Dec 3;383(23):2283-2285. - PMID 33264550

5

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D) : a phase 2-3 randomised trial

enthalten in: The lancet. Gastroenterology & hepatology | 2018

von Adams, R. | Brown, E. | Brown, L. | +14

CommentIn: Lancet Gastroenterol Hepatol. 2018 Mar;3(3):143-145. - PMID 29254888

1
[1]